Expert Opinion on Investigational Drugs, Volume 31, Issue 2 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 31, Issue 2 (2022)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Volume 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Editorial

Editorial
Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine
Lynnette A. Averill & Chadi G. Abdallah
Pages: 133-137
Published online: 21 Feb 2022
First Page PreviewforInvestigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine | Full Text | References | PDF (183.1 KB) | EPUB
  • 8066 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Telacebec: an investigational antibacterial for the treatment of tuberculosis (TB)
Bei Shi Lee & Kevin Pethe
Pages: 139-144
Published online: 26 Jan 2022
AbstractforTelacebec: an investigational antibacterial for the treatment of tuberculosis (TB) | Full Text | References | PDF (316 KB) | EPUB
  • 357 Views
  • 5 CrossRef citations
  • 0Altmetric

Perspective

Article
JAK inhibitors in crohn’s disease: ready to go?
Cecilia Dell’Avalle, Ferdinando D’Amico, Roberto Gabbiadini, Arianna Dal Buono, Nicola Pugliese, Alessandra Zilli, Federica Furfaro, Gionata Fiorino, Mariangela Allocca, Laurent Peyrin-Biroulet & Silvio Danese
Pages: 145-161
Published online: 14 Feb 2022
AbstractforJAK inhibitors in crohn’s disease: ready to go? | Full Text | References | PDF (2.8 MB) | EPUB
  • 782 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials
Pankaj Aggarwal, Mazen Noureddin, Stephen Harrison, Sophie Jeannin & Naim Alkhouri
Pages: 163-172
Published online: 10 Feb 2022
AbstractforNonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials | Full Text | References | PDF (1.2 MB) | EPUB
  • 638 Views
  • 3 CrossRef citations
  • 0Altmetric
Novel investigational treatments for ventilator-associated pneumonia and critically ill patients in the intensive care unit
Rachael Cusack, Alexis Garduno, Khalid Elkholy & Ignacio Martín-Loeches
Pages: 173-192
Published online: 02 Feb 2022
AbstractforNovel investigational treatments for ventilator-associated pneumonia and critically ill patients in the intensive care unit | Full Text | References | PDF (946.7 KB) | EPUB
  • 489 Views
  • 3 CrossRef citations
  • 0Altmetric
Current options and investigational drugs for the treatment of eosinophilic esophagitis
Sonsoles Tamarit-Sebastian, Francisco Miguel Ferrer-Soler & Alfredo J Lucendo
Pages: 193-210
Published online: 31 Jan 2022
AbstractforCurrent options and investigational drugs for the treatment of eosinophilic esophagitis | Full Text | References | PDF (787.5 KB) | EPUB
  • 905 Views
  • 2 CrossRef citations
  • 0Altmetric
Prospect of CAR T-cell therapy in acute myeloid leukemia
Talha Badar, Alak Manna, Martha E. Gadd, Mohamed A. Kharfan-Dabaja & Hong Qin
Pages: 211-220
Published online: 24 Jan 2022
AbstractforProspect of CAR T-cell therapy in acute myeloid leukemia | Full Text | References | PDF (804.5 KB) | EPUB
  • 538 Views
  • 0 CrossRef citations
  • 0Altmetric
Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?
Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker & Daniel Neureiter
Pages: 221-233
Published online: 07 Feb 2022
AbstractforChemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned? | Full Text | References | PDF (4.4 MB) | EPUB
  • 284 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles